Status:
COMPLETED
Comparison of Antisecretory Effect of a Single Dose of Rabeprazole 20 mg and Omeprazole 20 mg in Obese Subjects
Lead Sponsor:
Nantes University Hospital
Conditions:
Gastroesophageal Reflux
Eligibility:
All Genders
18-55 years
Phase:
PHASE2
Brief Summary
This study aims to determine, in obese subjects, the antisecretory effect of a single dose of placebo, rabeprazole 20 mg and omeprazole 20 mg using 24h gastric pH monitoring, in a prospective, monocen...
Eligibility Criteria
Inclusion
- Helicobacter negative obese subject (BMI 30 to 40),
- 18 to 55 years old,
- normal hepatic biology and morphology (echography)
- Contraceptive methods in women.
Exclusion
- Subjects with previous abdominal surgery, with diabetic or immunosuppressive treatment.
Key Trial Info
Start Date :
April 1 2010
Trial Type :
INTERVENTIONAL
End Date :
July 1 2010
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01136317
Start Date
April 1 2010
End Date
July 1 2010
Last Update
September 24 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Nantes
Nantes, France, 44093